Speaker Profile
PhD, CTO, EarlyDiagnostics
Biography
Dr. Ni serves as the Chief Technology Officer at EarlyDx, bringing more than two decades of experience in research and product development to the team, His expertise spans a wide range of disciplines, including physics, molecular biology, and cancer genomics. Before joining EarlyDx, Dr. Ni held a senior scientist at Cynvenio Biosystems, now known as LungLife AI, where he played a pivotal role in the development of Cynvenio's FISH test for early lung cancer detection using circulating tumor cells. Dr. Ni currently leads EarlyDx's NIH SBIR project focused on assay development. He earned his Ph.D. in Physics from the City University of New York and completed his postdoctoral training in SingleCell Cancer Genomics at Harvard University.
Talk
Methylome-Based Liquid Biopsy for Early Detection of Multiple Cancers
EarlyDx's MethylScan technology delivers costeffective cfDNA methylome sequencing, facilitating sensitive and specific detection and localization of various types of cancer.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Laura J. van 't Veer, UCSF
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Sidransky, Johns Hopkins
Pioneer Honoree: Helmy Eltoukhy
Pioneer Honoree: AmirAli Talasaz, Guardant Health - Utilities of Liquid Biopsy in Biomarker Testing
- Laura Vent Veer, UCSF - Status Quo of Clinical Liquid Biopsy (PANEL)
Chair: Helmy Eltoukhy, Guardant Health
- Sadakatsu Ikeda, Tokyo Medical University
- Heather Parsons, Dana-Farber Cancer Institute
- Sanjay Popat, The Royal Marsden - Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
Chair: Anne-Renee Hartman, Adela Bio
- AmirAli Talasaz, Guardant Health
- Heather Parsons, Dana-Farber Cancer Institute
- Mary Pat Lancelotta, Adaptive Bio
- Sylvia Katina Plevritis, Stanford - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing (PANEL)
Chair: Tom Beer, Exact Sciences
- Wendy Rubinstein, National Cancer Institute
- Sheila D. Walcoff, Goldbug Strategies LLC - Keynote: Pioneering Liquid Nucleic Acids Tumor Fragments in Health and Diseases
- David Sidransky, Johns Hopkins - New Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- David Sidransky, Johns Hopkins
- Dan Laudau, NY Genome Center
- Daniel De Carvalho, University of Toronto - Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
Chair: Debra Fraser-Howze, D. Fraser Associates
- Belinda Nedjai, Wolfson Institute of Population Health
- Elisabeth Adams, Aquarius Population Health Limited - NCI Showcase
- Xiaohui Ni, Early Dx
- Daniel Kim, UCSC
